Weight Loss

Majority of GLP-1 users are using it primarily for weight loss, says Morgan Stanley’s Kaufman

Pamela Kaufman, Morgan Stanley, joins ‘Money Movers’ to discuss the company’s GLP-1 growth survey, ...

 Read More

Weight Loss

Ro CEO on telehealth and the impact of weight loss drugs

Zachariah Reitano, Ro CEO, joins ‘Money Movers’ to discuss the impact of weight loss ...

 Read More

Weight Loss

New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studies

Dr. Angela Fitch, Knownwell chief medical officer and president of Obesity Medicine Association, joins ...

 Read More

Weight Loss

Efficacy of Pfizer’s weight-loss drug ‘inferior’ to others on the market, says UBS’s Colin Bristow

Colin Bristow, UBS managing director, joins ‘Fast Money’ to discuss Pfizer’s weight-loss drug. For ...

 Read More

Weight Loss

Pfizer’s weight-loss pill won’t be in direct competition with Ozempic, says BMO’s Evan Seigerman

Evan Seigerman, BMO Capital Markets, joins ‘Closing Bell Overtime’ to discuss his ‘Buy’ rating ...

 Read More